O

OncoMyx Therapeutics

11 employees

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
drug development
ovarian cancer
oncolytic virus
acute myeloid leukemia
Health Diagnostics
sarcoma
lung metastasis
Oncology
multiple myeloma
immunotherapy
virology
Therapeutics
w
medical oncology
hematology
bladder cancer
Medical
lung cancer

Date founded

2018

Funding rounds raised

Total raised

$50M

from 8 investors over 8 rounds

O

OncoMyx Therapeutics raised $50M on December 9, 2021

Investors: Delos Capital, Korea Investment Partners, LYZZ CAPITAL, City Hill Ventures, Madison Partners, Xeraya Capital, Lumira Ventures and B Capital Group

FAQ